Bessemer Group’s Collegium Pharmaceutical COLL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4K | Sell |
140
-9
| -6% | -$257 | ﹤0.01% | 2061 |
|
|
2025
Q1 | $4K | Sell |
149
-4
| -3% | -$107 | ﹤0.01% | 2075 |
|
|
2024
Q4 | $5K | Hold |
153
| – | – | ﹤0.01% | 1989 |
|
|
2024
Q3 | $6K | Buy |
153
+33
| +28% | +$1.29K | ﹤0.01% | 1839 |
|
|
2024
Q2 | $4K | Hold |
120
| – | – | ﹤0.01% | 1739 |
|
|
2024
Q1 | $5K | Buy |
+120
| New | +$5K | ﹤0.01% | 1696 |
|
|
2023
Q1 | – | Sell |
-215
| Closed | -$5K | – | 1956 |
|
|
2022
Q4 | $5K | Hold |
215
| – | – | ﹤0.01% | 1553 |
|
|
2022
Q3 | $3K | Sell |
215
-16
| -7% | -$223 | ﹤0.01% | 1831 |
|
|
2022
Q2 | $4K | Sell |
231
-269
| -54% | -$4.66K | ﹤0.01% | 1574 |
|
|
2022
Q1 | $10K | Buy |
500
+18
| +4% | +$360 | ﹤0.01% | 1378 |
|
|
2021
Q4 | $9K | Buy |
482
+213
| +79% | +$3.98K | ﹤0.01% | 1438 |
|
|
2021
Q3 | $5K | Hold |
269
| – | – | ﹤0.01% | 1502 |
|
|
2021
Q2 | $6K | Hold |
269
| – | – | ﹤0.01% | 1404 |
|
|
2021
Q1 | $6K | Buy |
+269
| New | +$6K | ﹤0.01% | 1368 |
|
|
2020
Q3 | – | Sell |
-12,200
| Closed | -$214K | – | 1408 |
|
|
2020
Q2 | $214K | Hold |
12,200
| – | – | ﹤0.01% | 1136 |
|
|
2020
Q1 | $199K | Buy |
+12,200
| New | +$199K | ﹤0.01% | 998 |
|
|
2019
Q4 | – | Sell |
-53,300
| Closed | -$612K | – | 1654 |
|
|
2019
Q3 | $612K | Buy |
+53,300
| New | +$612K | ﹤0.01% | 828 |
|
|
2019
Q2 | – | Sell |
-32,300
| Closed | -$489K | – | 1671 |
|
|
2019
Q1 | $489K | Hold |
32,300
| – | – | ﹤0.01% | 800 |
|
|
2018
Q4 | $555K | Buy |
+32,300
| New | +$555K | ﹤0.01% | 718 |
|